Leflunomide (LFN), an FDA-approved drug for the treatment of rheumatoid arthritis, is an inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH)10–12. The gene discussed is DHODH; the disease is rheumatoid arthritis.